Larimar Therapeutics Inc. (LRMR)
2.64
-0.39 (-12.87%)
At close: Mar 03, 2025, 3:59 PM
2.60
-1.52%
After-hours: Mar 03, 2025, 06:37 PM EST
Larimar Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 26.75M | 26.82M | 70.1M | 68.15M | 1.01M | 49.33M | 40.78M | 32.35M | 35.59M | 58.1M | 35.52M | 9.94M |
| Short-Term Investments | 60.04M | 91.6M | n/a | 24.49M | 43.05M | 68.73M | 61.27M | 96.84M | 149.48M | 57.36M | n/a | n/a |
| Long-Term Investments | 1.34M | 1.34M | 1.34M | 1.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 630K |
| Other Long-Term Assets | 659K | 638K | 669K | 419K | 90K | 57K | 57K | 61K | 94K | 242K | 743K | n/a |
| Receivables | n/a | n/a | 208K | 32K | n/a | 1.54M | 946K | 347K | 1.32M | n/a | 1.62M | n/a |
| Inventory | n/a | n/a | -208K | -32K | 3.16M | n/a | n/a | 1.00 | n/a | n/a | n/a | n/a |
| Other Current Assets | 3.38M | 2.31M | 1.9M | 5.28M | 3.74M | 2.17M | 1.93M | 1.36M | 1.71M | 1.74M | 224K | 389K |
| Total Current Assets | 90.17M | 120.74M | 72.2M | 97.95M | 4.75M | 121.33M | 104.92M | 130.9M | 188.11M | 117.2M | 37.36M | 10.32M |
| Property-Plant & Equipment | 3.76M | 3.69M | 4.46M | 4.98M | 361K | 375K | 528K | 661K | 902K | 79K | 37K | 32K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 5.76M | 5.67M | 6.46M | 6.73M | 451K | 432K | 585K | 722K | 996K | 321K | 780K | 662K |
| Total Assets | 95.94M | 126.41M | 78.67M | 104.69M | 5.2M | 121.76M | 105.51M | 131.62M | 189.11M | 117.52M | 38.14M | 10.99M |
| Account Payables | 1.28M | 1.69M | 1.66M | 2.63M | 3.54M | 909K | 3.02M | 2.57M | 7.5M | 2.35M | n/a | n/a |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | -5.46M | n/a | -2.57M | -2.94M | n/a | n/a | n/a |
| Short-Term Debt | 837K | 1.22M | 1.19M | 1.03M | 97K | 5.46M | n/a | 3.59M | 2.94M | 1.38M | n/a | n/a |
| Other Current Liabilities | 7.39M | 7.8M | 6M | 5.33M | 2.26M | 6.94M | 4.27M | 6.3M | 9.05M | 3.17M | 2.92M | 2.93M |
| Total Current Liabilities | 9.51M | 10.71M | 8.85M | 8.99M | 5.89M | 13.31M | 7.29M | 9.89M | 16.54M | 6.9M | 2.92M | 2.93M |
| Long-Term Debt | 4.71M | 4.8M | 5.41M | 6M | n/a | 15.19M | 20M | n/a | 3.45M | 6.18M | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1 | n/a | n/a | n/a |
| Total Long-Term Liabilities | 4.71M | 4.8M | 5.41M | 6M | 14.92M | 15.19M | 20M | n/a | 3.45M | 6.18M | n/a | n/a |
| Total Liabilities | 14.21M | 15.5M | 14.25M | 14.99M | 5.89M | 28.49M | 27.29M | 9.89M | 20M | 13.08M | 2.92M | 2.93M |
| Total Debt | 5.55M | 5.41M | 6M | 6.52M | 97K | 20.64M | 20M | 3.59M | 6.39M | 7.56M | n/a | n/a |
| Common Stock | 43K | 43K | 18K | 15K | 6K | 37K | 27K | 27K | 27K | 23K | 1K | 1K |
| Retained Earnings | -188.55M | -151.6M | -116.25M | -65.61M | -23.13M | -350.94M | -289.58M | -237.55M | -179.67M | -105.39M | -68.91M | -54.88M |
| Comprehensive Income | 81K | -31K | -0.00 | 1K | 35K | -33K | -58K | -80K | -207K | -35K | n/a | n/a |
| Shareholders Equity | 81.72M | 110.9M | 64.41M | 89.69M | -694K | 93.27M | 78.22M | 121.73M | 169.11M | 104.44M | 35.22M | 8.06M |
| Total Investments | 61.38M | 91.6M | 1.34M | 24.49M | 43.05M | 68.73M | 61.27M | 96.84M | 149.48M | 57.36M | n/a | 630K |